This study is currently not recruiting participants.

Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

The primary purpose of the study is to identify a gene expression and/or mutational profile that can separate primary cutaneous squamous cell carcinoma (cSCC) tumors that have high risk of recurrence compared to primary cutaneous squamous cell carcinoma (cSCC) tumors that have low risk of recurrence using a prognostic molecular test (RT-PCR and RNA sequencing).

Description

The primary purpose of the study is to identify a gene expression and/or mutational profile that can separate primary cutaneous squamous cell carcinoma (cSCC) tumors that have high risk of recurrence compared to primary cutaneous squamous cell carcinoma (cSCC) tumors that have low risk of recurrence using a prognostic molecular test (RT-PCR and RNA sequencing).

Details
Condition Cutaneous Squamous Cell Carcinoma
Age 100years or below
Clinical Study IdentifierTX8349
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.